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Objective: Transposition of the great arteries is currently treated by performing the
arterial switch operation. Dilatation of the neoaortic root is a late complication with
unknown cause. Samples of patients with untreated transposition of the great arteries
and patients with normally related great arteries were compared to investigate a
possible role for vascular remodeling in the dilatation process.
Methods: Aortic and pulmonary artery vessel wall and sinus samples were taken
from 20 untreated human heart specimens with transposition of the great arteries and
9 age-matched, normal, postmortem human heart specimens, divided into 2 groups
according to age. Routine histology and immunohistochemical staining for smooth
muscle cell differentiation markers -smooth muscle actin, SM22, and calponin
were performed.
Results: This study revealed structural differences between the normal aorta and
pulmonary artery in the early group, which became more pronounced in the late
group. In the early stage in transposition of the great arteries, no marked differences
were seen between the aorta and pulmonary artery. With increasing age, however,
there was a pronounced down-regulation of all smooth muscle cell markers in the
pulmonary artery.
Conclusions: There is a structural difference between the normal neonatal aorta and
pulmonary artery. The great arteries in transposition of the great arteries differ from
each other and from normal vessels, indicating a structural vascular difference in
transposition of the great arteries. In the pulmonary artery and sinus of untreated
transposition of the great arteries, there is a dedifferentiation of smooth muscle cells
with increasing age that we could not correlate to altered flow. This structural
abnormality might provide an explanation for the neoaortic root dilatation that has
been reported as a late complication of the arterial switch operation.
Transposition of the great arteries (TGA) is a heart defect that is foundin approximately 5% of all newborns with congenital heart malfor-mations.1 Currently, the operation of choice for TGA is the arterialswitch operation (ASO). The first ASO was performed by Jatene andcolleagues2 in 1975. Currently, most children undergo the ASO inthe neonatal period with excellent survival3; however, late compli-
cations are being reported.4-6 One of the complications that needs further investi-
gation is the neoaortic root dilatation that occurs after the ASO and the neoaortic
valve insufficiency that may be associated with this dilatation.7,8 With this opera-
tion, the anatomic pulmonary root stays in place and becomes the neoaortic root that
is subsequently subjected to systemic pressures.
Vascular remodeling occurs as a consequence of altered hemodynamic circum-
stances.9,10 In vessels exposed to alterations in shear stress and pressure differences,
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vascular remodeling and the mechanisms involved have
been described.11,12 Also, the behavior of the pulmonary
autograft in the systemic circulation, as seen after the Ross
procedure, has been examined in animal studies, showing an
increase in smooth muscle cells (SMCs).13
To our knowledge, there are no reports on the histologic
findings in the sinus and vessel wall of patients with TGA
before or after surgical treatment. To elucidate the cause of
late dilatation after ASO, we studied the histologic charac-
teristics of the aorta and pulmonary artery (PA) of patients




Samples of the human aortic and pulmonary vessel wall were
obtained from 20 postmortem, untreated heart specimens with
TGA (from patients aged 1 day-9 months) and 9 normal, postmor-
tem heart specimens (from patients aged 1 day-9 months) from the
Leiden collection (Department of Anatomy and Embryology, Lei-
den University Medical Center, The Netherlands). Eleven heart
specimens showed TGA with intact ventricular septum (IVS),
whereas 9 other specimens showed TGA with ventricular septal
defect (VSD) (Figure 1, Table 1). From the same specimens,
samples of aortic and pulmonary sinus were obtained. The sinus
samples of the aorta were taken from the noncoronary sinus. The
procedures were followed in accordance with institutional guide-
lines.
None of the control patients died of a cardiac or vessel-related
cause. According to clinical reports, all patients with TGA died as
the result of cardiac failure. We distinguished an early group
(patients aged 1 day-3 months) and a late group (patients aged
4-9 months). As mentioned in the clinical reports, a Blalock-
Hanlon septectomy had been performed in 6 patients with TGA,
and a morphologically patent ductus arteriosus was described in 12
patients (Table 1).
The specimens were fixed in ethanol and glycerin. The pieces
of aortic and pulmonary vessel wall, as well as the sinus, were then
routinely processed for light microscopy. Transverse sections (5
m) were mounted serially onto glycerin-coated glass slides and
Starfrost glass slides (Klinipath BV, Duiven, The Netherlands).
The paraffin-embedded tissue sections were deparaffinated, after
which they were stained with hematoxylin-eosin, resorcin-fuchsin,
Figure 1. Example of a specimen with transposition of the great
arteries with the squares representing the sample area. The
samples in normal heart specimens were removed at the same
location. Aortic (Ao) vessel wall; pulmonary artery (PA) vessel
wall; aortic sinus (AoS); PA sinus (PAS).














1 1 d TGA  PDA
2 2 d TGA  PDA
3 4 d TGA  BH  PDA
4 6 d TGA  PDA
5 9 d TGA  PDA
6 12 d TGA  BH  PDA
7 17 d TGA  PDA
8 17 d TGA  VSD  PDA
9 22 d TGA  PDA
10 1 mo TGA  VSD  PDA
11 2 mo TGA  VSD
12 2 mo TGA  VSD
13 3 mo TGA  BH  PDA
14 3 mo TGA  VSD
15 4 mo TGA  VSD  BH
16 5 mo TGA  VSD
17 6 mo TGA  VSD  BH
18 7 mo TGA  BH
19 8 mo TGA  VSD
20 9 mo TGA  PDA
VSD, Ventricular septal defect; BH, Blalock-Hanlon septectomy; PDA,
patent ductus arteriosus; TGA, transposition of the great arteries.
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and modified van Gieson to study the morphology of the vessel
walls.
Immunohistochemistry
For the identification of SMCs in the vessel wall and sinuses, the
antibodies anti--SM actin (1A4, Sigma, St Louis, Mo), anti-
SM2214,15 (provided by Dr S. Sartore, Padova, Italy), and anti-
human calponin16 (Sigma) were applied.
The sections were deparaffinated, followed by treatment with
0.3% H2O2 in phosphate-buffered saline (PBS) (pH 7.3) for 15
minutes to extinguish endogenous peroxidase activity. After this,
sections were rinsed briefly in PBS twice and then in PBS with
0.05% Tween-20. Immunohistochemical staining was performed
using 3-hour incubation with the primary antibodies diluted in PBS
with 0.05% Tween-20 and 1% bovine serum albumin (Sigma)
(1A4 1:10,000; anti-SM22 1:100; anti-human calponin 1:10,000).
Bound antibodies were detected using 1-hour incubation with
horseradish peroxidase-conjugated rabbit anti-mouse antibody or
horseradish peroxidase-conjugated swine anti-rabbit antibody (di-
lution 1:200, Dako A/S, Glostrup, Denmark), depending on
whether the primary antibody was monoclonal or polyclonal. Con-
trol stainings were performed using PBS-Tween 0.05% and bovine
serum albumin 1% as primary antibody.
The sections were then exposed to 0.04% diaminobenzidine
tetrahydrochloride in 0.05 mol/L Tris-maleate buffer (pH 7.6) with
0.006% H2O2 for 10 minutes. After rinsing, the sections were
counterstained with Mayer’s hematoxylin for 7 seconds, dehy-
drated, and mounted in Entellan (Merck, Darmstadt, Germany).










Aorta PA Aorta PA
Early group
1  N  
2    
3    
4    
5    
6    
Late group
7    
8    
9    
Hearts with TGA
Early group
1    
2    
3    
4 N N  
5    
6    
7 N N  
8    
9 N   
10    
11    
12    
13    
14    
Late group
15    
16    
17    
18    
19    
20    
H&E, Hematoxylin-eosin; RF, resorcin-fuchsin; PA, pulmonary artery; N, not
judgeable. : extreme; : very; : more than average; :
average; : less than average; : very little.
TABLE 3. Immunohistochemistry of normal and TGA spec-
imens












Aorta PA PA PA
Early group
1    
2    
3    
4    
5    
6    
Late group
7    
8    
9    
Hearts TGA with (sinus and vessel wall)
Early group
1    
2    
3    
5    
6    
8    
10    
11    
Late group
15    
16    
17    
18    
19    
20    
1A4, Anti--smooth muscle actin; SMCs, smooth muscle cells; PA, pulmo-
nary artery.: more than average;: average;: less than average;:
little; : very little; : extremely little. All values: PA compared with
aorta of same specimen. Specimens 4, 7, 9, and 12 to 14 were not
judgeable in the TGA group.
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The tissue sections stained with actin antibodies were then
microscopically divided into sections of 1 mm2.
Results
Routine Histology
The histologic findings in both the vessel wall and sinus of
normal hearts are summarized in Table 2. In the normal
vessels stained with hematoxylin-eosin, a difference in cel-
lular pattern between aorta and PA was distinguished in the
early group. The cells in the aorta were more compactly
organized compared with the PA, which became even more
apparent in the late group. Also, the SMCs in the aortic
media were mostly oriented longitudinally, whereas in the
PA, this was not the case.
In regard to the elastic properties of the vessel wall in the
early and late groups, the aortic elastic laminae were ori-
ented in a densely organized, longitudinal fashion with
increasing age as opposed to the laminae in the PA, which
showed distinct fragmentation in a loosely organized, less
dense structure (Figure 2).
In the hearts with TGA, routine histology did not reveal
clear differences between the vessel wall and sinus of aorta
and PA in the early and late groups. The orientation of the
cells in both aorta and PA, stained with hematoxylin-eosin,
appeared to be similar, in contrast with the findings in the
normal vessels (Table 2, Figure 2). In general, the organi-
zation of cells was less compact compared with that in
normal vessels.
Immunohistochemistry
The results are summarized in Table 3. In the normal hearts,
both aorta and PA in the early and late groups showed
actin-positive SMCs in the entire media of the vessel wall.
In the PA, the staining pattern appeared more variable
compared with the aorta (Figure 3, a and b). This variation
became more evident with increasing age (Figure 3, e and
f ), which is supported by the findings in routine histology.
In TGA, actin-positive SMCs were also present in the
complete media of both aorta and PA. No change in staining
Figure 2. Resorcin-fuchsin staining of the vessel wall in normal hearts and hearts with TGA. a, b, Case 3; c, d, case
9; e, f, case 14 (Table 2). N, Normal heart; L, luminal side of the vessel.
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Figure 3. a-d, All figures showing anti--smooth muscle actin (1A4) staining of the vessel wall of normal hearts
and hearts with TGA in the early group. a, b, Case 1; c, d, case 8; e, j, 1A4 staining of the vessel wall of normal
hearts and hearts with TGA in different age groups; e, f, case 9; g, h, case 15; i, j, case 18 (Table 3). ‹, Border
between media and adventitia; 7, thickness of nonstained intima and media.
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pattern of the aorta was noted with increasing age (Figure 3,
c, g, i). The PA, however, did show evident changes. In the
early group, the entire pulmonary media stained positive for
1A4 (Figure 3, d). With increasing age, a loss of actin
positivity was seen in the inner and outer media (Figure 3,
h) and was most marked in the inner media of the PA in the
late group (Figure 3, j). The graphic relationship between
age and area of negative actin staining in the media of aorta
and PA in normal hearts and hearts with TGA is shown in
Figure 5. Comparable results were obtained with the con-
tractile SMC markers SM22 and calponin.
Study of the sinus wall of the aorta and PA in TGA
showed results comparable to those found in the media of
the vessel wall. We observed a marked loss of 1A4 expres-
sion in the PA sinus wall with increasing age, in comparison
with the aortic sinus (Figure 4, a-d). These findings were
again confirmed by SM22 and calponin expression that
stayed within the -smooth muscle actin (1A4) boundaries.
The differences seen in the actin-stained sections of the
vessel walls in the early and late groups are shown in Figure
5.
Discussion
The original aortic and pulmonary roots remain in situ after
the ASO. Thus, the original aortic (neopulmonary) root
remains connected to the right ventricle, whereas the orig-
inal pulmonary (neoaortic) root remains attached to the left
ventricle. One of the late complications of the ASO is
dilatation of the neoaortic root with the possibility of (neo)
aortic valve insufficiency. In this perspective, we studied the
structure of the great arteries and their roots in normal hearts
and untreated hearts with TGA from patients aged 1 day to
9 months.
We had the unique opportunity to study the natural
maturation of the great arteries and their roots in TGA, that
is, in untreated, postmortem specimens from the preswitch
era. The older patients with TGA in this series have lived for
Figure 5. The trend between age and actin-negative area in
normal aorta and PA vessel wall and sinuses, and in aorta and PA
vessel wall and sinuses in TGA. The normal aorta and PA lose a
small but not substantial amount of actin with increasing age.
The aorta in TGA shows behavior more like normal vessels with
increasing age. The PA in TGA shows a very clear trend in loss
of actin-positive smooth muscle cells as the patient grows older.
Figure 4. a, b, 1A4 staining of the aortic and PAS in the late TGA group (case 18, Table 3). c, The same PAS, stained
with -SM22. d, The PAS stained with calponin.
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some time because of the existence of a VSD or a large
ductus arteriosus together with the atrial septectomy that
had been performed in the neonatal phase.
At birth, the structure of the aortic and pulmonary vessel
walls and sinuses in normal hearts is different, and these
differences become more evident with increasing age. No
striking differences in structure were observed between the
aorta and the PA of very young specimens with TGA, but a
down-regulation of all SMC markers was observed in the
PA of the older specimens with TGA. The expression of
SMC markers (-smooth muscle actin, SM22, and calpo-
nin) showed a significant decrease in the pulmonary vessel
wall in TGA with increasing age.
Literature data indicate that, during development, the
expression of SMC markers in the human aorta changes as
the SMC phenotype develops. In the normal human aorta,
SM actin accounts for approximately 80% of the fetal aortic
media and increases to approximately 97% and 98% in the
6-month-old child and in the adult aortic media, respective-
ly.17 No literature data are available on the SM-actin com-
position of the PA with increasing age.
In untreated TGA, the main vessels (ie, aorta and PA) are
subjected to abnormal hemodynamic conditions. In both
TGA with IVS and with VSD, pulmonary flow is increased.
In TGA with VSD, both pulmonary flow and pressure are
increased. In both conditions, pulmonary hypertension will
develop rapidly.
Vascular remodeling as a response to changes in pressure
has been reported;12,18 however, these reports are limited to
the changes in vessel wall structure in the aorta or other
smaller systemic arteries. Data on remodeling of the PA also
exist.19 These reports deal with the changes occurring in the
pulmonary vascular bed mainly as a response to pulmonary
hypertension.20,21 Increased vessel wall thickness, elevated
extracellular matrix proliferation, and vascular SMC hyper-
trophy or hyperplasia are described as the characteristic
changes that take place in vascular remodeling as a response
to elevated pressure, rather than dedifferentiation of pulmo-
nary SMCs.22,23
After the Ross procedure, an increase in -SM actin, as
well as an increase in the number of SMCs in the wall of the
pulmonary autograft, has been reported.13
In the PA in TGA, we observed a decrease in the ex-
pression of SMCs with increasing age, whereas hypertrophy
or an increase in the number of SMCs is observed in the
pulmonary vessel wall after the Ross procedure and in
pulmonary hypertension. Therefore, elevated pressure con-
ditions are probably not the best way to explain this obser-
vation.
It is important to look into the role of blood flow in vessel
wall remodeling in both TGA with IVS and with VSD,
because pulmonary blood flow is increased in both condi-
tions. Flow-mediated arterial remodeling has been de-
scribed in animal models and humans.24,25 Buus and col-
leagues24 describe the changes in vessel wall structure in
animal arteries exposed to high and low flow. In the low-
flow model, phenotypic changes of SMCs were observed.
Expression of the SMC differentiation marker 1A4 re-
mained unchanged in both the high- and low-flow vessel
walls, whereas calponin showed a significant decrease in the
low-flow arteries, thus indicating dedifferentiation of SMCs
with no change in proliferation activity of the SMCs com-
pared with controls. In the high-flow arteries, dedifferenti-
ation was also detected, using desmin mRNA as a differen-
tiation marker, but this was not as significant as in the
low-flow arteries and was most likely related to a higher
proliferation activity.
In our study group, the PA vessel wall and sinus in TGA
showed decreased expression of calponin. Notably, this
decrease was also observed with 1A4 and SM22 in the PA
samples of hearts with TGA with and without VSD. This
implies that the observed remodeling of the SMCs in the
“older” PA samples of hearts with TGA cannot be explained
by flow-mediated mechanisms.
Schaper and colleagues26 describe dedifferentiation of
vascular SMCs in growing collateral coronary arteries. This
phenomenon is observed with SMC differentiation markers
1A4 and calponin. However, these dedifferentiated SMCs
are primarily found in the neointima of the growing coro-
nary collaterals. We investigated whether the SMC dedif-
ferentiation that we observed in the “older” PA samples of
hearts with TGA was specific for formation of a neointima.
In our material, the phenomenon was found in both inner
and outer media without changes in layering of the elastic
laminae, whereas no intimal thickening occurred. This was
also the case for the sinus region. Thus, the SMC down-
regulation in PA samples of hearts with TGA that we
observed could not be explained by neointima formation.
To our best knowledge, this is the first report on struc-
tural differences of the great vessels between hearts with
TGA and normal hearts. With the use of SMC differentia-
tion markers, we were able to demonstrate a difference in
SMC structure in the pulmonary wall and sinus between
hearts with TGA and normal hearts, as well as a clear trend
toward dedifferentiation of SMCs in the PA of “older”
hearts with TGA. We could not explain this SMC down-
regulation by pressure- or flow-mediated mechanisms. Fur-
thermore, the observation was not related to neointima
formation. Thus, the findings in this study might imply that
the PA in TGA is predetermined to develop in an essentially
different way than the PA in a normal heart.
It could be speculated that early surgical repair (ASO) of
TGA with or without VSD might reverse or decrease the
reduction of SMCs in the PA vessel and sinus wall. How-
ever, further study will be needed to support this hypothesis.
As far as we know, no data have been reported on a
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difference in late neoaortic root dilatation between ASOs
performed early and late.
Conclusion
We found that the PA in untreated TGA showed a clear
trend in reduction of actin-staining SMCs in the media
throughout the first year of life. These histologic findings
show that vascular remodeling occurs in the pulmonary
vessel during the natural course of TGA. Increased flow or
pressure conditions cannot explain these changes, thus in-
dicating that the PA in TGA is structurally different com-
pared with the PA in a normal heart. This observation may
offer an explanation for the neoaortic dilatation that has
been reported in the clinical follow-up of patients with TGA
after the ASO.8 Clinical observations that the vascular struc-
ture is different in patients with TGA, not only in the heart
but also in other parts of the vascular system, have not been
reported to date, but may have been overlooked.
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